Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02199977 |
Recruitment Status :
Completed
First Posted : July 25, 2014
Last Update Posted : December 15, 2015
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Fever Malaria | Other: Free Malaria Rapid Diagnostic Test Other: Conditional ACT voucher Other: Malaria Rapid Diagnostic test for a charge | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 444 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Health Services Research |
Official Title: | Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector |
Study Start Date : | June 2014 |
Actual Primary Completion Date : | July 2015 |
Actual Study Completion Date : | July 2015 |
Arm | Intervention/treatment |
---|---|
test only (free)
The participant is entitled to a free malaria rapid diagnostic test, but no ACT voucher.
|
Other: Free Malaria Rapid Diagnostic Test
Malaria RDT is offered free if patients choose to be tested |
test (free) & conditional ACT voucher
The participant is entitled to a free malaria rapid diagnostic test, and an ACT voucher conditional on a positive test result.
|
Other: Free Malaria Rapid Diagnostic Test
Malaria RDT is offered free if patients choose to be tested Other: Conditional ACT voucher Participants will be eligible to receive a drug subsidy for a set amount (in the form of a voucher) conditional on a positive malaria test. When a conditional subsidy is offered, it is valid for use on a "Green Leaf" approved malaria drug. |
test only (not free)
The participant is entitled to a malaria rapid diagnostic test for a charge (i.e., not for free), but no ACT voucher.
|
Other: Malaria Rapid Diagnostic test for a charge
Participants can receive a malaria RDT for a set amount (i.e., not for free). |
test (not free) & conditional ACT voucher
The participant is entitled to a malaria rapid diagnostic test for a charge (i.e., not for free), and an ACT voucher conditional on a positive test result.
|
Other: Conditional ACT voucher
Participants will be eligible to receive a drug subsidy for a set amount (in the form of a voucher) conditional on a positive malaria test. When a conditional subsidy is offered, it is valid for use on a "Green Leaf" approved malaria drug. Other: Malaria Rapid Diagnostic test for a charge Participants can receive a malaria RDT for a set amount (i.e., not for free). |
- Effect of conditional drug subsidy on proportion of participants who choose to receive a free malaria diagnostic test [ Time Frame: Within two days of group assignment ]The primary outcome of interest is to compare the proportion of participants who choose to receive a free malaria diagnostic test when they can receive a subsidy for a discounted drug conditional on a positive test compared to those without the offer of a conditional subsidy.
- Effect of malaria RDT subsidy on the uptake of testing (free versus paid RDT) [ Time Frame: Within 2 days of group assignment ]
- Effect of a conditional ACT subsidy on uptake of testing when the RDT is not free. [ Time Frame: Within 2 days of group assignment ]
- Percent of clients with a negative test, a positive test or no test who choose to purchase an ACT in all four groups. [ Time Frame: Within 2 days of test results ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year and older (Child, Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Client is older than 1 year
- Client has fever or history of fever or feeling unwell with a malaria-like illness within the last 24 hours
- Client or their parent/legal guardian consents to participate
Exclusion Criteria:
- Client has signs of severe disease or other problem requiring immediate referral to a community health worker (CHW) / health facility
- Client has already sought treatment, purchased medicine or taken medicine for the current illness.
Note:
If more than one febrile person who meet the inclusion criteria are found in a single household, all of the individuals will be enrolled in the same group, but only one individual (the first enrolled) will be used for the purposes of the analysis.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02199977
Kenya | |
Moi University | |
Eldoret, Kenya |
Principal Investigator: | Wendy O'Meara, PhD | Duke University |
Responsible Party: | Duke University |
ClinicalTrials.gov Identifier: | NCT02199977 |
Other Study ID Numbers: |
Pro00052602 1R01AI110478-01 ( U.S. NIH Grant/Contract ) |
First Posted: | July 25, 2014 Key Record Dates |
Last Update Posted: | December 15, 2015 |
Last Verified: | December 2015 |
Malaria Antimalarial subsidy Malaria rapid diagnostic test (RDT) public-private partnership |
Malaria Protozoan Infections Parasitic Diseases Infections Vector Borne Diseases |